Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Penny Stocks

Why Is Cenntro (NASDAQ:CENN) Down 46.02% Pre-Market With a USD 100 Million Share Program?

Cenntro (NASDAQ:CENN) fell 46.02% to USD 0.1607 in pre-market trading on November 4, 2026. The only announcement identified, dated November 3, 2026, said 20 LS450 electric trucks were delivered under a New York voucher program, representing more than USD 2.44 million in revenue. No …

Vinay Lochav | 04 November 2026

Why Is iPower (NASDAQ:IPW) Down 11.59% Before the Open?

No company announcement dated November 2, 3 or 4, 2026 was identified. The drop follows a reverse split that took effect on October 26, 2026, and trading in a very small share base tends to be volatile after such a split, though that is …

Vinay Lochav | 04 November 2026

Is Dilution Weighing on SHF Holdings (NASDAQ:SHFS) After a 13.94% Slide?

No company announcement dated November 2, 3 or 4, 2026 was identified. The most recent filing found was a regulatory filing dated October 26, 2026, so the move appears to reflect ongoing concern about dilution and the pending combination rather than a new headline.

Vinay Lochav | 04 November 2026

Why Is BrenX (NASDAQ:BRNX) Down 8.28% Ahead of Its Reverse Split Vote?

No press release, filing orEarningsreport dated November 2 to November 4, 2026 was identified. The stock is trading under USD 1 ahead of a shareholder vote on a reverse split, which may be shaping sentiment, although the company has not linked the two.

Vinay Lochav | 04 November 2026

Is InMed Pharmaceuticals (NASDAQ:INM) Penny Stock Dropping 9.52% Ahead of a Merger Vote?

The results arrived one day before aShareholdermeeting on the proposedMergerwith Mentari Therapeutics, which is scheduled for November 4, 2026. No separate offering or delisting announcement dated November 3 or November 4, 2026 was identified.

Vinay Lochav | 04 November 2026

Is RxSight (NASDAQ:RXST) Penny Stock Sliding 9.59% After a Sharp Third Quarter Revenue Fall?

The report showed a double-digit revenue decline, a lower gross margin and a wider loss, and the company gave no financial guidance. Management put the weakness mainly down to competitive pressure.

Vinay Lochav | 04 November 2026

Why Is BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sliding 7.76% Despite Its Cash Runway?

The decline more likely reflects continued weakness in a stock that has fallen sharply since the summer. On October 12, 2026, the company reported inducementOptionspriced at USD 3.31 per share, so the current price sits well below that level (calculated, about 35% lower). As …

Vinay Lochav | 04 November 2026

Is Axonex AI Group (NASDAQ:AXNX) Up 12.76% Pre-Market Despite No Confirmed Catalyst?

A company filing dated August 31, 2026 described a non-binding letter of intent with Sports One for aBusinesscombination, and any deal would need a definitive agreement andShareholderapproval. The company held about 69.78 BTC worth USD 4.118 million on June 30, 2026, against cash of …

Vinay Lochav | 04 November 2026

Is Sangrix (NASDAQ:SGRX) Down 12.51% Pre-Market on November 4, 2026 Ahead of Its Reverse Split?

A company release dated October 16, 2026 stated that 16 servers holding 128 Blackwell B300 GPUs were expected in Malaysia during the week of November 3, 2026, as part of a project described as anAcquisitionworth roughly USD 11 million.

Vinay Lochav | 04 November 2026

Is Cre8 Enterprise (NASDAQ:CRE) Sliding 9.43% Pre-Market on November 4, 2026 After an Acquisition Notice?

An 8-for-1 reverse share split took effect for trading on July 27, 2026, reducing Class A shares outstanding from about 7,758,868 to about 969,859. At USD 0.501 the stock sits below the USD 1.00Nasdaqbid threshold again. As a penny stock, it faces elevated volatility, …

Vinay Lochav | 04 November 2026
Support

Hi! How can we help you today?

Loading…